Department of Cellular Pathology, John Radcliffe Hospital, Oxford, UK.
Northern Ireland Molecular Pathology Laboratory, Centre for Cancer Research and Cell Biology, Queens University, Belfast, UK.
J Pathol Clin Res. 2019 Apr;5(2):100-107. doi: 10.1002/cjp2.124. Epub 2019 Feb 27.
Clinical trials rely on multidisciplinary teams for successful delivery. Pathologists should be involved in clinical trial design from the outset to ensure that protocols are optimised to deliver maximum data collection and translational research opportunities. Clinical trials must be performed according to the principles of Good Clinical Practice (GCP) and the trial sponsor has an obligation to ensure that all of the personnel involved in the trial have undergone training relevant to their role. Pathologists who are involved in the delivery of clinical trials are often required to undergo formal GCP training and may additionally undergo Good Clinical Laboratory Practice training if they are involved in the laboratory analysis of trials samples. Further training can be provided via trial-specific investigator meetings, which may be either multidisciplinary or discipline-specific events. Pathologists should also ensure that they undertake External Quality Assurance schemes relevant to the area of diagnostic practice required in the trial. The level of engagement of pathologists in academia and clinical trials research has declined in the United Kingdom over recent years. This paper recommends the optimal training and accreditation for pathologists undertaking clinical trials activities with the aim of facilitating increased engagement. Clinical trials training should ideally be provided to all pathologists through centrally organised educational events, with additional training provided to pathologists in training through local postgraduate teaching. Pathologists in training should also be strongly encouraged to undertake GCP training. It is hoped that these recommendations will increase the number of pathologists who take part in clinical trials research in order to ensure a high level and standard of data collection and to maximise the translational research opportunities.
临床试验依赖多学科团队的成功交付。病理学家应从一开始就参与临床试验设计,以确保方案得到优化,从而最大限度地收集数据和开展转化研究。临床试验必须遵循良好临床规范(GCP)的原则,试验赞助商有义务确保所有参与试验的人员都接受过与其角色相关的培训。参与临床试验交付的病理学家通常需要接受正式的 GCP 培训,如果他们参与试验样本的实验室分析,可能还需要接受良好临床实验室实践培训。进一步的培训可以通过特定于试验的调查员会议提供,这些会议可以是多学科的,也可以是特定于学科的。病理学家还应确保他们参与与试验中所需的诊断实践领域相关的外部质量保证计划。近年来,英国病理学家在学术界和临床试验研究中的参与度有所下降。本文建议对从事临床试验活动的病理学家进行最佳的培训和认证,以促进更多的参与。临床试验培训应通过中央组织的教育活动理想地提供给所有病理学家,并通过当地研究生教学为接受培训的病理学家提供额外的培训。也应强烈鼓励接受培训的病理学家进行 GCP 培训。希望这些建议能够增加参与临床试验研究的病理学家人数,以确保高水平和高标准的数据收集,并最大限度地利用转化研究机会。